Public Health Europe - European Commission - EU

Interested parties are invited to share their views via a questionnaire, until 30 July, to help explore several options in view of the revision of the legislation.

The Commission is complementing the successful EU Vaccines Strategy with a strategy on COVID-19 therapeutics to support the development and availability of much-needed COVID-19 therapeutics, including for the treatment of ‘long COVID'.

Stakeholders are invited to share views on how the Directive has improved patients’ rights to healthcare abroad and its role to strengthen European cooperation in the area of rare and complex diseases. This consultation is open for responses until 27 July 2021.

The purpose of the EHDS is to promote health-data exchange and support research on new preventive strategies, as well as on treatments, medicines, medical devices and outcomes. The consultation will remain open for responses until 26 July 2021.